Jeffrey S. Reichard, PharmD, MS, BCOP, BCPS

home / authors / jeffrey-s-reichard-pharmd-ms-bcop-bcps

Articles

Clinical Outcomes of Oral Anticancer Regimens in NSCLC Patients Managed in an Integrated Health-System Specialty Pharmacy Program

Clinical Outcomes of Oral Anticancer Regimens in NSCLC Patients Managed in an Integrated Health-System Specialty Pharmacy Program

Kelly F. Tysinger, PharmD, BCOP;Kaitlyn W. Miller, PharmD, BCOP;Heather D. Nelkin, PharmD, BCOP, DPLA;Jeffrey S. Reichard, PharmD, MS, BCOP, BCPS
March 31st 2022

Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.

Read More

Strategies for Successful IDN-based Specialty Pharmacy: The Financial Perspective

Strategies for Successful IDN-based Specialty Pharmacy: The Financial Perspective

Jeffrey S. Reichard, PharmD, MS, BCOP, BCPS;Joe Maki, Senior Director, Pharmacy Business Operations, Novant Health
August 27th 2019

An in-house specialty pharmacy can provide significant financial gain for health systems by preventing revenue from being diverted to outside pharmacies.

Read More

Latest Updated Articles

raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Milan, Italy - APRIL 10, 2021: CDC logo on laptop screen seen through an optical prism. Illustrative editorial image from CDC website.
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Image credit: catalin | stock.adobe.com
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders